NEW YORK (Reuters Health) – Urologists from China report that the alpha-adrenergic receptor antagonist tamsulosin is a good first-line drug for outpatient medical expulsive therapy (MET) in patients…
NEW YORK (Reuters Health) – Among very low birth weight (VLBW) preterm infants, those treated with oral ibuprofen for patent ductus arteriosus have higher rates of closure than…
NEW YORK (Reuters Health) – Over time, cervical intraepithelial neoplasia (CIN) grade 2 eventually resolves spontaneously in about two-thirds of adolescent and young adult women, according to findings…
NEW YORK (Reuters Health) – The tumor volume threshold of 0.5 mL for clinically insignificant prostate cancer, established in the early 1990s, remains valid, according to researchers who…
NEW YORK (Reuters Health) – Anemia that develops in hepatitis C virus (HCV) patients during treatment with peginterferon-alfa and ribavirin (PEG-IFN/RBV) may be a good sign, new research…
NEW YORK (Reuters Health) – Ultrasound-guided high-intensity focused ultrasound (HIFU) ablation and the levonorgestrel intrauterine system (LNG-IUS) offer less invasive options for treating women with symptomatic adenomyosis, according…
NEW YORK (Reuters Health) – A molecular complex of aspirin and phosphatidylcholine called PL2200 seems to protect against acute gastroduodenal erosion and ulceration in older adults at risk…
NEW YORK (Reuters Health) – Elevated systolic blood pressure and low diastolic blood pressure are associated with increased risk of cardiovascular disease (CVD) among patients with type 2…
NEW YORK (Reuters Health) – In adolescents and adults with active eosinophilic esophagitis (EoE), a 15-day induction course of nebulized budesonide is sufficient to induce histologic remission and…
NEW YORK (Reuters Health) – A newer ureteral stent, designed to be more comfortable than an older stent, actually isn’t, according to results of a randomized controlled trial.…